Skip to main content

Table 3 Cerebral perfusion measurement

From: Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review

Reference Triple-H components Prophylactic/Therapeutic CBF Technique Measuring location Timing after Intervention
Ekelund, 2002 [18] isovolemic hemodilution or hypervolemic hemodilution Therapeutic 133Xe SPECT Whole brain < 24 hours
Mori, 1995 [14] hypervolemic hemodilution Therapeutic 123I-IMP e.s.c. Ipsilateral to craniotomy 5 to 7 days
Yamakami, 1987 [21] hypervolemia Prophylactic 133Xe e.s.c. Ipsilateral to craniotomy < 24 hours
Lennihan, 2000 [13] hypervolemia Prophylactic 133Xe e.s.c. Whole brain < 24 hours
5 to 7 days
12 to 14 days
Tseng, 2003 [23] hypervolemia Therapeutic XeCT Whole brain < 24 hours
Jost, 2005 [22] hypervolemia Therapeutic PET Whole brain < 24 hours
Muizelaar, 1986 [25] hypertension Therapeutic 133Xe e.s.c. Whole brain < 24 hours
Touho, 1992 [20] hypertension Both XeCT Ipsilateral to craniotomy < 24 hours
Darby, 1994 [24] hypertension Therapeutic XeCT Whole brain < 24 hours
Origitano, 1990 [15] Triple-H Prophylactic 133Xe e.s.c. Whole brain < 24 hours
Muench, 2007 [19] Triple-H or hypertension or hypervolemic hemodilution Prophylactic thermal diffusion microprobe in flow territory distal to aneurysm < 24 hours
  1. CBF, cerebral blood flow; e.s.c., external scintillation counter.